Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Lemonaid Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Lemonaid Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 193 · Grade C

Lemonaid Health

Visit Lemonaid Health Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 68 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Lemonaid Health a bad call — it's best for readers who want to understand the membership obligation alongside the medication charge. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
34
Supply Reliability
95
74
Transparency
90
80
Access Breadth
93
80
Clinical Oversight
92
74
Track Record
88
77
CoreAge RxBrief Score 94 · 68Lemonaid Health

Price, coverage & the tracker

CoreAge RxLemonaid Health
Brief Score94/100 (A)68/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Medication and membership separate

Standard compounded medication advertised at $299/month; membership free for the first month, then $49 monthly.

Longer plans require prepayment and can renew before their supplied weeks end. Confirm the full charge and exact renewal date.

Full price details

Compounded semaglutide offered; complete selected membership and supply quote unknown; monthly medication advertised at $299 plus membership advertised free for the first month then $49 monthly, with different prepaid options; earlier listing: From $348/mo (starting dose, plus a separate fee, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Medication and membership separate

Standard compounded medication advertised at $299/month; membership free for the first month, then $49 monthly. Microdose and branded plans differ.

Confirm the full prepaid charge and renewal date; medication and care are separate unless a selected extended agreement combines them.

Full price details

Compounded tirzepatide offered; complete selected membership and supply quote unknown; standard monthly medication advertised at $299 plus membership advertised free for the first month then $49 monthly, separate from microdose and branded plans; earlier listing: Not disclosed

CoverageUS only; restrictions by state, confirmed at intakeWeight-loss FAQ expressly says not all fifty states; confirm treatment eligibility for your physical location. Generic medical-team licensure is not a weight-loss coverage map.
Brand-name accessNot confirmedNames Wegovy, Ozempic and LillyDirect Zepbound routes; membership, medication and insurance arrangements are separate.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Lemonaid Health: Lemonaid separates recurring weight-loss membership from medication, with prepaid options and state-specific limits.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.